Dual inhibition of the renin system by aliskiren and valsartan

被引：16

作者：

Birkenhaeger, Willem H.

Staessen, Jan A. ^{[1
]}

机构：

[1] Univ Leuven, Dept Cardiovasc Dis, Div Hypertens & Cardiovasc Rehabil, Studies Coordinating Ctr, BE-3000 Louvain, Belgium

[2] Erasmus Univ, Rotterdam, Netherlands

来源：

LANCET | 2007年 / 370卷 / 9583期

关键词：

CONVERTING-ENZYME-INHIBITORS; RECEPTOR BLOCKERS; ANGIOTENSIN; COMBINATION; THERAPY; DISEASE;

D O I：

10.1016/S0140-6736(07)61099-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：195 / 196

页数：2

共 12 条

[1] Hyperkalemia in hospitalized patients -: Causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines [J].

Acker, CG ;

Johnson, JP ;

Palevsky, PM ;

Greenberg, A .

ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (08) :917-924

[2] Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2 [J].

Ferrario, CM ;

Jessup, J ;

Chappell, MC ;

Averill, DB ;

Brosnihan, KB ;

Tallant, EA ;

Diz, DI ;

Gallagher, PE .

CIRCULATION, 2005, 111 (20) :2605-2610

[3]

HIGGINS B, 2006, MANAGEMENT HYPERTENS

[4] Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: A systematic review of the efficacy and safety data [J].

MacKinnon, Martin ;

Shurraw, Sabin ;

Akbari, Ayub ;

Knoll, Greg A. ;

Jaffey, James ;

Clark, Heather D. .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 48 (01) :8-20

[5] Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors:: the CHARM-Added trial [J].

McMurray, JJV ;

Östergren, J ;

Swedberg, K ;

Granger, CB ;

Held, P ;

Michelson, EL ;

Olofsson, B ;

Yusuf, S ;

Pfeffer, MA .

LANCET, 2003, 362 (9386) :767-771

[6] Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial [J].

Oparil, Suzanne ;

Yarows, Steven A. ;

Patel, Samir ;

Fang, Hui ;

Zhang, Jack ;

Satlin, Andrew .

LANCET, 2007, 370 (9583) :221-229

[7] Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers [J].

Raebel, Marsha A. ;

McClure, David L. ;

Simon, Steven R. ;

Chan, K. Arnold ;

Feldstein, Adrianne ;

Andrade, Susan E. ;

Lafata, Jennifer Elston ;

Roblin, Douglas ;

Davis, Robert L. ;

Gunter, Margaret J. ;

Platt, Richard .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (01) :55-64

[8] RISE IN PLASMA-CONCENTRATION OF ALDOSTERONE DURING LONG-TERM ANGIOTENSIN(II)SUPPRESSION [J].

STAESSEN, J ;

LIJNEN, P ;

FAGARD, R ;

VERSCHUEREN, LJ ;

AMERY, A .

JOURNAL OF ENDOCRINOLOGY, 1981, 91 (03) :457-465

[9] Oral renin inhibitors [J].

Staessen, Jan A. ;

Li, Yan ;

Richart, Tom .

LANCET, 2006, 368 (9545) :1449-1456

[10] Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating Telmisartan, Ramipril, and their combination in high-risk patients: The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials [J].

Teo, KK .

AMERICAN HEART JOURNAL, 2004, 148 (01) :52-61

← 1 2 →